Skip to main content

Atossa Therapeutics, Inc 10-K for FY2025

Atossa Therapeutics, Inc. (ATOS)

10-K 2026-03-25 For: 2025-12-31
View Original
Added on April 10, 2026

About this 10-K

Atossa Therapeutics, Inc filed this 10-K on March 25, 2026, covering the fiscal year ended December 31, 2025 (FY2025).

Headline figures

Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$34.77M
compared with a net loss of $25.5M a year earlier
Diluted EPS
-$4.04
compared with -$3.04 a year earlier